These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
242 related articles for article (PubMed ID: 26307680)
1. CEBPD amplification and overexpression in urothelial carcinoma: a driver of tumor metastasis indicating adverse prognosis. Wang YH; Wu WJ; Wang WJ; Huang HY; Li WM; Yeh BW; Wu TF; Shiue YL; Sheu JJ; Wang JM; Li CF Oncotarget; 2015 Oct; 6(31):31069-84. PubMed ID: 26307680 [TBL] [Abstract][Full Text] [Related]
2. Rsf-1/HBXAP overexpression is independent of gene amplification and is associated with poor outcome in patients with urinary bladder urothelial carcinoma. Liang PI; Wu LC; Sheu JJ; Wu TF; Shen KH; Wang YH; Wu WR; Shiue YL; Huang HY; Hsu HP; Chen YH; Chen LT; Li CF; Liao AC J Clin Pathol; 2012 Sep; 65(9):802-7. PubMed ID: 22685262 [TBL] [Abstract][Full Text] [Related]
3. MiR-193b Mediates CEBPD-Induced Cisplatin Sensitization Through Targeting ETS1 and Cyclin D1 in Human Urothelial Carcinoma Cells. Lin SR; Yeh HC; Wang WJ; Ke HL; Lin HH; Hsu WC; Chao SY; Hour TC; Wu WJ; Pu YS; Huang AM J Cell Biochem; 2017 Jun; 118(6):1563-1573. PubMed ID: 27918099 [TBL] [Abstract][Full Text] [Related]
4. Importin-11 overexpression promotes the migration, invasion, and progression of bladder cancer associated with the deregulation of CDKN1A and THBS1. Zhao J; Shi L; Zeng S; Ma C; Xu W; Zhang Z; Liu Q; Zhang P; Sun Y; Xu C Urol Oncol; 2018 Jun; 36(6):311.e1-311.e13. PubMed ID: 29602637 [TBL] [Abstract][Full Text] [Related]
5. Amplification-driven BCL6-suppressed cytostasis is mediated by transrepression of FOXO3 and post-translational modifications of FOXO3 in urinary bladder urothelial carcinoma. Wu WR; Lin JT; Pan CT; Chan TC; Liu CL; Wu WJ; Sheu JJ; Yeh BW; Huang SK; Jhung JY; Hsiao MS; Li CF; Shiue YL Theranostics; 2020; 10(2):707-724. PubMed ID: 31903146 [TBL] [Abstract][Full Text] [Related]
6. GPX2 underexpression indicates poor prognosis in patients with urothelial carcinomas of the upper urinary tract and urinary bladder. Chang IW; Lin VC; Hung CH; Wang HP; Lin YY; Wu WJ; Huang CN; Li CC; Li WM; Wu JY; Li CF World J Urol; 2015 Nov; 33(11):1777-89. PubMed ID: 25813210 [TBL] [Abstract][Full Text] [Related]
7. MiR-324-5p/PTPRD/CEBPD axis promotes papillary thyroid carcinoma progression via microenvironment alteration. Yang Y; Xia S; Zhang L; Wang W; Chen L; Zhan W Cancer Biol Ther; 2020 Jun; 21(6):522-532. PubMed ID: 32151175 [TBL] [Abstract][Full Text] [Related]
8. Angiogenesis Driven by the CEBPD-hsa-miR-429-VEGFA Signaling Axis Promotes Urothelial Carcinoma Progression. Chan TC; Hsing CH; Shiue YL; Huang SK; Hsieh KL; Kuo YH; Li CF Cells; 2022 Feb; 11(4):. PubMed ID: 35203290 [TBL] [Abstract][Full Text] [Related]
9. miR-149 represses metastasis of hepatocellular carcinoma by targeting actin-regulatory proteins PPM1F. Luo G; Chao YL; Tang B; Li BS; Xiao YF; Xie R; Wang SM; Wu YY; Dong H; Liu XD; Yang SM Oncotarget; 2015 Nov; 6(35):37808-23. PubMed ID: 26498692 [TBL] [Abstract][Full Text] [Related]
10. Heat-shock protein 70-2 (HSP70-2) expression in bladder urothelial carcinoma is associated with tumour progression and promotes migration and invasion. Garg M; Kanojia D; Seth A; Kumar R; Gupta A; Surolia A; Suri A Eur J Cancer; 2010 Jan; 46(1):207-15. PubMed ID: 19914824 [TBL] [Abstract][Full Text] [Related]
11. DDR2 overexpression in urothelial carcinoma indicates an unfavorable prognosis: a large cohort study. Tsai MC; Li WM; Huang CN; Ke HL; Li CC; Yeh HC; Chan TC; Liang PI; Yeh BW; Wu WJ; Lim SW; Li CF Oncotarget; 2016 Nov; 7(48):78918-78931. PubMed ID: 27793038 [TBL] [Abstract][Full Text] [Related]
12. Biological significance of MYC and CEBPD coamplification in urothelial carcinoma: Multilayered genomic, transcriptional and posttranscriptional positive feedback loops enhance oncogenic glycolysis. Chan TC; Chen YT; Tan KT; Wu CL; Wu WJ; Li WM; Wang JM; Shiue YL; Li CF Clin Transl Med; 2021 Dec; 11(12):e674. PubMed ID: 34954904 [TBL] [Abstract][Full Text] [Related]
13. ING5 inhibits cancer aggressiveness via preventing EMT and is a potential prognostic biomarker for lung cancer. Zhang F; Zhang X; Meng J; Zhao Y; Liu X; Liu Y; Wang Y; Li Y; Sun Y; Wang Z; Mei Q; Zhang T Oncotarget; 2015 Jun; 6(18):16239-52. PubMed ID: 25938545 [TBL] [Abstract][Full Text] [Related]
14. Overexpression of Transcription Termination Factor 1 is Associated with a Poor Prognosis in Patients with Colorectal Cancer. Ueda M; Iguchi T; Nambara S; Saito T; Komatsu H; Sakimura S; Hirata H; Uchi R; Takano Y; Shinden Y; Eguchi H; Masuda T; Sugimachi K; Yamamoto H; Doki Y; Mori M; Mimori K Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1490-8. PubMed ID: 26036188 [TBL] [Abstract][Full Text] [Related]
15. INHBA overexpression indicates poor prognosis in urothelial carcinoma of urinary bladder and upper tract. Lee HY; Li CC; Huang CN; Li WM; Yeh HC; Ke HL; Yang KF; Liang PI; Li CF; Wu WJ J Surg Oncol; 2015 Mar; 111(4):414-22. PubMed ID: 25488476 [TBL] [Abstract][Full Text] [Related]
16. Ack1 overexpression promotes metastasis and indicates poor prognosis of hepatocellular carcinoma. Lei X; Li YF; Chen GD; Ou DP; Qiu XX; Zuo CH; Yang LY Oncotarget; 2015 Dec; 6(38):40622-41. PubMed ID: 26536663 [TBL] [Abstract][Full Text] [Related]
17. DPP4/CD26 overexpression in urothelial carcinoma confers an independent prognostic impact and correlates with intrinsic biological aggressiveness. Liang PI; Yeh BW; Li WM; Chan TC; Chang IW; Huang CN; Li CC; Ke HL; Yeh HC; Wu WJ; Li CF Oncotarget; 2017 Jan; 8(2):2995-3008. PubMed ID: 27936466 [TBL] [Abstract][Full Text] [Related]
18. The miR-506-Induced Epithelial-Mesenchymal Transition is Involved in Poor Prognosis for Patients with Gastric Cancer. Sakimura S; Sugimachi K; Kurashige J; Ueda M; Hirata H; Nambara S; Komatsu H; Saito T; Takano Y; Uchi R; Sakimura E; Shinden Y; Iguchi T; Eguchi H; Oba Y; Hoka S; Mimori K Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1436-43. PubMed ID: 25707493 [TBL] [Abstract][Full Text] [Related]
19. The E3 ubiquitin ligase SIAH2 is a prosurvival factor overexpressed in oral cancer. Hsieh SC; Kuo SN; Zheng YH; Tsai MH; Lin YS; Lin JH Anticancer Res; 2013 Nov; 33(11):4965-73. PubMed ID: 24222137 [TBL] [Abstract][Full Text] [Related]
20. TGFBI Expression in Cancer Stromal Cells is Associated with Poor Prognosis and Hematogenous Recurrence in Esophageal Squamous Cell Carcinoma. Ozawa D; Yokobori T; Sohda M; Sakai M; Hara K; Honjo H; Kato H; Miyazaki T; Kuwano H Ann Surg Oncol; 2016 Jan; 23(1):282-9. PubMed ID: 25448803 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]